Diclofenac Epolamine System
Product Images NDC 68788-4115

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Diclofenac Epolamine (NDC 68788-4115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Diclofenac 01)

Chemical Structure (Diclofenac 01)
Chemical structure diagram of Diclofenac Epolamine, showing the molecular structure of Diclofenac with two chlorine atoms and an epolamine moiety labeled as 2-(pyrrolidin-1-yl)ethanol.*
FDA Label Image

Figure 1 (Diclofenac 02)

Figure 1 (Diclofenac 02)
A line graph comparing the percent of patients improved between Diclofenac Patch and Placebo. The x-axis represents percent improvement from baseline, ranging from 10 to 100, and the y-axis represents the percent of patients improved, ranging from 0 to 100. Two lines are shown: one with black circles for Diclofenac Patch and another with white squares for Placebo, illustrating greater patient improvement with Diclofenac Patch across various improvement percentages.*
FDA Label Image

Figure 2 (Diclofenac 03)

Figure 2 (Diclofenac 03)
A line graph showing the percent of patients improved as a function of percent improvement from baseline. It compares two groups: one using Diclofenac Patch and the other using Placebo, with the Diclofenac group consistently showing higher improvement across the range.*
FDA Label Image

Figure 3 (Diclofenac 04)

Figure 3 (Diclofenac 04)
A scatter plot chart comparing the percent improvement from baseline against the percent of patients improved. The graph includes two data sets, one for Diclofenac Patch and one for Placebo, showing higher improvement percentages for patients using the Diclofenac Patch across the range of improvement values.*
FDA Label Image

Figure 4 (Diclofenac 05)

Figure 4 (Diclofenac 05)
A line graph comparing the percent improvement from baseline on the x-axis with the percent of patients improved on the y-axis, for Diclofenac Patch versus placebo. The graph shows that a higher percentage of patients improved with Diclofenac Patch across increasing levels of percent improvement compared to placebo.*
FDA Label Image

Diclofenac Epolamine 1.3% Patch (Diclofenac 06)

Diclofenac Epolamine 1.3% Patch (Diclofenac 06)
Label for Diclofenac Epolamine 1.3% Patch, a topical adhesive patch containing 0.013 g of diclofenac epolamine. The label includes temperature storage instructions, warning statements, and manufacturer information from Altergon Italia Srl, with labeling by Preferred Pharmaceuticals Inc. It also features bilingual application directions in English and Spanish.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.